High dietary inflammatory index (DII), which quantifies the inflammatory potential of diet, is associated with increased ...

Researchers developed a nasal antibody that blocks mugwort pollen, a major hay fever trigger in Europe and Central Asia.

Intranasal delivery of a monoclonal IgG1 antibody targeting mugwort pollen protected mice from allergic rhinitis and asthma ...

Approximately 40% of the European population are allergic to pollen, and their symptoms cause an estimated loss of 100 ...

A common hay fever trigger could be treated by placing a "molecular shield" in the nose within five years. Scientists have ...

Vaccine experts have developed an antibody that, when applied to the nose, intercepts allergens before they can trigger a ...

A large-scale bibliometric analysis maps global research on hydrogels as next-generation drug delivery systems for cancer ...

Eleva administers first dose of its Factor H biological treatment in C3-Glomerulopathy to healthy volunteersFirst-in-human administration of CPV-104 marks a major step in drug development for the ...

An elderly man with immunoglobulin G4-related disease (IgG4-RD) with kidney involvement and monoclonal gammopathy was successfully treated with corticosteroid therapy. This case report was published ...

Eleva, a pioneer in discovering and developing previously inaccessible biologics based on a breakthrough technology platform, announced the first dosing in its phase 1 clinical study investigating the ...

Two medical researchers in China even provided a full list of foods participants reported that resulted in the lowest stroke rates.

The field of oncology has been revolutionized by the introduction of immune checkpoint inhibitors, with anti-PD-1 therapies offering durable responses in ...